Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant (Q37316838)
Jump to navigation
Jump to search
scientific article published on 20 June 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant |
scientific article published on 20 June 2013 |
Statements
1 reference
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant (English)
1 reference
Cliona M Rooney
1 reference
Ann M Leen
1 reference
Malcolm K Brenner
1 reference
Helen E Heslop
1 reference
Robert A Krance
1 reference
Alana Kennedy-Nasser
1 reference
Kathryn S Leung
1 reference
Ulrike Gerdemann
1 reference
Usha L Katari
1 reference
Stephen M Gottschalk
1 reference
Jacqueline M Keirnan
1 reference
Anastasia Papadopoulou
1 reference
John A Craddock
1 reference
Hao Liu
1 reference
Caridad A Martinez
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference